Wockhardt News

UK Government Announces Covid-19 Vaccination Contract Extension with Wockhardt

AstraZeneca/Oxford University Covid-19 vaccine MHRA approval

Wockhardt hosts visit of the UK Prime Minister

Wockhardt UK’s Amoxicillin Sodium 250mg, 500mg and 1g Powder for Solution for Injection

Wockhardt announces COVID-19 vaccine partnership with UK Government

Wockhardt UK launches Clobazam Oral Suspension 5mg/5ml, 10mg/5ml (150ml)

Introducing Co-codamol (Codeine phosphate, paracetamol) 30mg/500mg Oral Solution

Corporate Health Standard – Silver Award

Valued Partner Awards – Silver Award

Investors In People – Silver Award

Wockhardt UK Launches Levothyroxine 100mcg/5ml Oral Solution 150ml

Wockhardt UK Ltd Launches Pregabalin 20mg/ml Oral Solution

Wockhardt UK Ltd expands the ‘Cost Saving Brands’ Business with the addition of Oxeltra (oxycodone hydrochloride) to our new range products

Wockhardt UK Ltd Launches Yaltormin (metformin hydrochloride) as part of our new ‘Cost Saving Brands’ Business 

Hypurin® Porcine Insulin UK & Canada Commitment

Statement on Brexit and the supply of Hypurin® Insulin

Migril® tablets: FULLY AVAILABLE

Hypurin® Bovine Insulin Announcement